Sepsis mimics.

Number of identical pathophysiological mechanisms is shared by sepsis and other clinical conditions and diseases. This could lead to their nearly similar clinical phenotype. However, the early discrimination of them is crucial - treatment of particular diseases differs significantly, and the mortality of the vast majority of them is considerable. The differential diagnostics possibilities together with brief description of selected clinical conditions are discussed within the review.

• Publication year

  2019

• Venue

  Vnitrni lekarstvi

• Publication date

  2019-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.36290/vnl.2019.078PMID 31484485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review.

  2018cited by this paper
• Biomarkers in Sepsis.

  2018cited by this paper
• Epidemiology and Outcomes.

  2018cited by this paper
• Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus

  2018cited by this paper
• Diagnosis of hyperferritinemia in routine clinical practice.

  2017influential reference
• Catastrophic antiphospholipid syndrome: an update.

  2017cited by this paper
• Clinical Mimics: An Emergency Medicine-Focused Review of Sepsis Mimics.

  2017cited by this paper
• The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission

  2017cited by this paper
• Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome.

  2017cited by this paper
• Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome

  2017cited by this paper
• Novel biomarkers for sepsis: A narrative review.

  2017cited by this paper
• Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.

  2016cited by this paper
• Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia.

  2016influential reference
• Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes.

  2016cited by this paper
• Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

  2016cited by this paper
• Systemic inflammatory response syndrome criteria in defining severe sepsis.

  2015cited by this paper
• Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis

  2015cited by this paper
• Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome.

  2015cited by this paper
• Diagnostic Value of Presepsin for Sepsis

  2015cited by this paper
• How I treat hemophagocytic lymphohistiocytosis in the adult patient.

  2015cited by this paper
• Sepsis: a roadmap for future research.

  2015cited by this paper
• Central nervous system involvement in hemophagocytic lymphohistiocytosis: a single-center experience.

  2014cited by this paper
• Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.

  2014cited by this paper
• Chimeric antigen receptor T cells for sustained remissions in leukemia.

  2014cited by this paper
• Catastrophic antiphospholipid syndrome: a clinical review.

  2014influential reference
• Biomarkers in sepsis

  2013cited by this paper
• Immune Aspects of Sepsis and Hope for New Therapeutics

  2012cited by this paper
• Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome).

  2012cited by this paper
• CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis

  2012cited by this paper
• Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review

  2012cited by this paper
• Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis

  2012cited by this paper
• Biomarkers in the critically ill patient: procalcitonin.

  2011cited by this paper
• Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.

  2011influential reference
• A genomic storm in critically injured humans

  2011cited by this paper
• The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European Registry

  2011cited by this paper
• How I treat hemophagocytic lymphohistiocytosis.

  2011cited by this paper
• Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome

  2011influential reference
• Possible mediators for systemic capillary leak syndrome.

  2011cited by this paper
• Histiocytic disorders: recent insights into pathophysiology and practical guidelines.

  2010cited by this paper
• Narrative Review: The Systemic Capillary Leak Syndrome

  2010cited by this paper
• Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis

  2010cited by this paper
• Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway.

  2010cited by this paper
• Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.

  2010cited by this paper
• Hemophagocytic lymphohistiocytosis in Texas: Observations on ethnicity and race

  2010cited by this paper
• Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab.

  2010cited by this paper
• Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience.

  2010cited by this paper
• Ultrastructure of the microvessels in skeletal muscle in a case of systemic capillary leak syndrome.

  2009influential reference
• Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

  2009cited by this paper
• Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".

  2009cited by this paper
• Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks.

  2009cited by this paper
• Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases.

  2008cited by this paper
• Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis

  2008cited by this paper
• Lipopolysaccharide binding protein in a surgical intensive care unit: A marker of sepsis?*

  2008cited by this paper
• High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome

  2008cited by this paper
• Idiopathic systemic capillary leak syndrome (SCLS): case report and systematic review of cases reported in the last 16 years.

  2007cited by this paper
• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  2007cited by this paper
• Perforin-mediated target-cell death and immune homeostasis

  2006cited by this paper
• Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.

  2006cited by this paper
• Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

  2005cited by this paper
• A network-based analysis of systemic inflammation in humans

  2005cited by this paper
• Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

  2004cited by this paper
• Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.

  2002cited by this paper
• Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

  2002cited by this paper
• Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

  2001cited by this paper
• TREM-1 amplifies inflammation and is a crucial mediator of septic shock

  2001cited by this paper
• Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome.

  2001cited by this paper
• Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis.

  1997cited by this paper
• HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.

  1997cited by this paper
• Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society.

  1996cited by this paper
• Hypercytokinemia in familial hemophagocytic lymphohistiocytosis.

  1991cited by this paper

• Point-of-Care Ultrasound: A Multimodal Tool for the Management of Sepsis in the Emergency Department

  2023cites this paper
• Diagnostic pitfalls in neonatal hypertyrosinemia: a case report

  2023cites this paper